The non-pathogenic mycobacteria M. smegmatis and M. fortuitum induce rapid host cell apoptosis via a caspase-3 and TNF dependent pathway
© Bohsali et al; licensee BioMed Central Ltd. 2010
Received: 9 April 2010
Accepted: 10 September 2010
Published: 10 September 2010
The HIV pandemic raised the potential for facultative-pathogenic mycobacterial species like, Mycobacterium kansasii, to cause disseminating disease in humans with immune deficiencies. In contrast, non-pathogenic mycobacterial species, like M. smegmatis, are not known to cause disseminating disease even in immunocompromised individuals. We hypothesized that this difference in phenotype could be explained by the strong induction of an innate immune response by the non-pathogenic mycobacterial species.
A comparison of two rapid-growing, non-pathogenic species (M. smegmatis and M. fortuitum) with two facultative-pathogenic species (M. kansasii and M. bovis BCG) demonstrated that only the non-pathogenic bacteria induced strong apoptosis in human THP-1 cells and murine bone marrow-derived macrophages (BMDM) and dendritic cells (BMDD). The phospho-myo-inositol modification of lipoarabinomannan (PI-LAM) isolated from non-pathogenic species may be one of the cell wall components responsible for the pro-inflammatory activity of the whole bacteria. Indeed, PI-LAM induces high levels of apoptosis and IL-12 expression compared to the mannosyl modification of LAM isolated from facultative-pathogenic mycobacteria. The apoptosis induced by non-pathogenic M. smegmatis was dependent upon caspase-3 activation and TNF secretion. Consistently, BALB/c BMDM responded by secreting large amounts of TNF upon infection with non-pathogenic but not facultative-pathogenic mycobacteria. Interestingly, C57Bl/6 BMDM do not undergo apoptosis upon infection with non-pathogenic mycobacteria despite the fact that they still induce an increase in TNF secretion. This suggests that the host cell signaling pathways are different between these two mouse genotypes and that TNF is necessary but not sufficient to induce host cell apoptosis.
These results demonstrate a much stronger induction of the innate immune response by non-pathogenic versus facultative-pathogenic mycobacteria as measured by host cell apoptosis, IL-12 and TNF cytokine induction. These observations lend support to the hypothesis that the strong induction of the innate immune response is a major reason for the lack of pathogenicity in fast-growing mycobacteria.
Facultative-pathogenic mycobacterial species cause disseminating mycobacterial infections in humans that are defective in the acquired immune response (IR). For example, M. kansasii and M. avium are often found as opportunistic pathogens in immunosuppressed individuals due to AIDS. In contrast, non-pathogenic mycobacteria of the M. fortuitum and M. smegmatis group do not cause disseminating disease even in immunosupressed individuals. Therefore, we hypothesized that the inability of non-pathogenic species to cause disease could be due to their strong capacity to induce an innate IR, which is sufficient to defend against these species of mycobacteria even in individuals with defective acquired immunity.
The capacity of infected macrophages to undergo apoptosis after infection is an efficient mechanism of innate IR against mycobacteria. Indeed, the induction of apoptosis of infected macrophages may induce direct killing of intracellular mycobacteria [3, 4]. In addition, mycobacteria contained in apoptotic bodies can be taken up via phagocytosis by uninfected bystander macrophages which are then able to kill the bacteria more efficiently . Furthermore the importance of macrophage apoptosis for the IR was underscored by the recent findings that host susceptibility or resistance to mycobacterial infections could be linked to the capacity of the infected macrophages to undergo necrosis or apoptosis, respectively. Consistently, virulent M. tuberculosis strains express proteins implicated in inhibiting host cell apoptosis such as the superoxide dismutase A (SodA), catalase G (KatG) and NuoG which is part of the NDH-1 protein complex. The deletion of any of these genes strongly attenuates the virulence of the bacteria suggesting that host cell apoptosis inhibition is a virulence pathway [7–9].
In primary human alveolar macrophages the facultative-pathogenic mycobacteria (M. kansasii and M. bovis BCG) induced significantly more apoptosis then four different virulent strains of M. tuberculosis after 5 days of infection . Interestingly, M. smegmatis induces significant apoptosis in differentiated human THP-1 cells after only 24 h , suggesting the presence of potent mycobacterial ligands capable of inducing host cell signaling. The phospho-myo-inositol-lipoarabinomannan (PI-LAM) isolated from the cell wall of an unidentified fast-growing mycobacterial species, also referred to Ara-LAM, could be one such ligand, since it has been shown to induce host cell apoptosis [11, 12].
The host cell cytokine response during mycobacterial infections is regulated by mitogen activated protein kinase (MAPK) pathways. The facultative-pathogenic M. avium induced a profoundly different host cell signaling response when compared to the non-pathogenic M. smegmatis . In particular, the infection with M. smegmatis led to an increased p38 and ERK1/2 MAPKs activity in BMDMs which was necessary for increased TNF secretion . Furthermore, this increase in MAPKs was dependent upon prolonged stimulation of calmodulin/calmodulin kinase and cAMP/protein kinase A pathways . In addition, sphingosine kinase, phosphoinositide-specific phospholipase C and conventional protein kinase C were all implicated in M. smegmatis-induced activation of Erk1/2 . One downstream target of the MAPK p38 was determined to be the transcription factor cyclic AMP response element binding protein (CREB) which was more activated in M. smegmatis-infected cells .
In order to understand why non-pathogenic mycobacteria are strongly attenuated we compared their capacity to induce an innate IR to that of facultative-pathogenic mycobacteria. The induction of apoptosis and the stimulation of TNF expression in macrophages were analyzed and in both cases the macrophage response was much stronger for the non-pathogenic mycobacteria than the facultative-pathogenic mycobacteria. The induction of TNF secretion was important for the increase in caspase-3-dependent host cell apoptosis in BMDM. Furthermore, purified PI-LAM of the nonpathogenic mycobacterial species interacted with the TLR-2 and induced apoptosis and IL-12 p40 expression, whereas the purified Man-LAM of the facultative-pathogenic mycobacteria had no such activity. Altogether, facultative-pathogenic mycobacteria induce less of an innate immune response in macrophages relative to non-pathogenic mycobacteria.
Results and Discussion
Non-pathogenic mycobacteria induce increased host cell apoptosis
The induction of macrophage apoptosis has been implicated in innate host defense against mycobacteria. The importance of apoptosis in innate immune response was demonstrated by the attenuation of a pro-apoptotic Mtb mutant in immunodeficient SCID mice . In a previous study it was demonstrated that facultative-pathogenic mycobacteria (M. kansasii and M. bovis BCG) induce more apoptosis then virulent mycobacteria in primary alveolar macrophages after five to seven days of infection. Interestingly, we demonstrated that M. smegmatis induces apoptosis of THP-1 cell already after 16 h of infection. The current results thus extend this initial observation to another fast-growing, non-pathogenic mycobacterial species. They indicate that the pro-apoptotic capacity might be a general characteristic of this group of mycobacteria but it would clearly be desirable to analyze more strains of mycobacteria in order to support this generalization.
The PI-LAM cell wall component of non-pathogenic mycobacteria mediates pro-inflammatory response
Overall, the results of the current study are very consistent with reported results demonstrating that the PI-LAM of an unidentified, fast-growing mycobacterial species induces host cell cytokine secretion and apoptosis . We extended these results to include PI-LAM of M. smegmatis and another PI-LAM of M. fortuitum , both of which induced host cell apoptosis and cytokine secretion. These results thus confirmed the general principle that PI-modified LAMs are pro-inflammatory. Furthermore, both of these PI-LAMs interact with macrophage TLR-2 but not TLR-4 receptors suggesting that the PI-component is the ligand of the TLR-2. Interestingly, despite the existence of a mycolic acid rich outermembrane in myocbacteria, it seems that LAM are still able to reach the outermost layers of the envelop to be exposed at the cell surface of the bacterium and thus exert their function as immunomodulins [29–31].
Non-pathogenic mycobacteria induce apoptosis via TNF and caspase-3 signaling pathways
TNF is a central pro-inflammatory cytokine that mediates and regulates innate immunity. TNF binding to TNF-R1 may lead to activation of NF- B, followed by gene transcription, production of inflammatory mediators and survival proteins. On the other hand, TNF binding may also initiate JNK protein kinase activation followed by activation of caspase-8 and downstream effector caspases such as caspase-3 resulting in apoptosis of the cell .
The increased cytokine secretion by macrophages upon infection with non-pathogenic M. smegmatis versus facultative-pathogenic M. avium has been demonstrated in human and murine macrophages and human neutrophils [15, 34, 35]. Our study builds upon these previous results by extending the analysis to include several non-pathogenic versus several facultative-pathogenic mycobacteria. We underscore that the strong pro-inflammatory response elicited by macrophage might be a more general characteristic of non-pathogenic mycobacteria. The increase of TNF secretion induced by M. smegmatis in murine BMDM is dependent upon stimulation of the cAMP/protein kinase A pathway which results in prolonged ERK1/2 activation. Furthermore, M. smegmatis infection leads to increase in TNF and NOS2 promoter activity but not infection with M. avium [15, 36]. The present study also extends upon these previous findings by linking the increase in TNF secretion to pro-apoptotic capacity of the non-pathogenic mycobacteria (Figure 6) and characterizing this apoptosis pathway as being caspase-dependent (Figure 6).
Non-pathogenic mycobacteria do not induce apoptosis in C57Bl/6 BMDM
These results demonstrate that the apoptotic response upon infection with non-pathogenic mycobacteria is dependent on the genotype of the host. The total amount of TNF secreted after M. smegmatis infection is reduced in C57Bl/6 versus BALB/c BMDMs (Figures 5A and 7C). For example at an MOI of 10:1 M. smegmatis induces 16.7 ± 2.7 ng/ml in BALB/c macrophages but only 4.4 ± 0.7 ng/ml in C57Bl/6 (p < 0.01). This could be interpreted as evidence for the role of decreased TNF secretion in the absence of M. smegmatis induced apoptosis of C57Bl/6 BMDMs. Nevertheless, infection of BMDMs of either mouse strain by M. fortuitum results in very similar induction of TNF secretion of 6.2 ± 2.0 ng/ml and 4.9 ± 1.1ng/ml in BALB/c and C57Bl/6, respectively (p > 0.05; Figures 5A and 7C) but still M. fortuitum just like M. smegmatis only induces apoptosis in BALB/c BMDMs but not C57Bl/6 cells (Figures 1B and 7A). We hypothesize thus that a certain amount of TNF secretion is necessary but not sufficient to mediate apoptosis induction of BMDMs. In a recent study we demonstrated a similar dissociation between induction of TNF secretion and host cell apoptosis. A pro-apoptotic Mtb mutant still induced TNF secretion but not host cell apoptosis in BMDMs lacking functional phagocyte NADPH oxidase (NOX2). It is thus intriguing to speculate that BALB/c and C57Bl/6 NOX2 enzymes react differently upon phagocytosis with non-pathogenic mycobacteria with the former inducing a stronger, prolonged activity resulting in a greater increase in ROS. It could be that this increase in ROS would tip the balance of the autocrine TNF-signaling towards apoptosis via increased JNK activation.
Differences in apoptosis induced by facultative-pathogenic and non-pathogenic mycobacteria in BALB/c and C57BL/6 dendritic cells
We hypothesized that the attenuation of non-pathogenic versus facultative-pathogenic mycobacteria could be explained in part by their strong induction of an innate immune response. Indeed, here we demonstrate that two representative strains of non-pathogenic mycobacterial species induce a stronger inflammatory response as measured by the cytokines TNF and IL-12. They also induce an increased apoptotic response in BMDMs and BMDDs. The PI-LAM and Man-LAM cell wall components of non-pathogenic and facultative-pathogenic mycobacteria, respectively, were analyzed. They could be a reason for the increased innate immune response since PI-LAM induces increased cytokine secretion and apoptosis response when compared to Man-LAM. We propose that the different mycobacterial species can be characterized by the following three functional groups: 1) Nonpathogenic which have no mechanisms to inhibit immune responses and contain a lot of PAMPs to induce a response, 2) facultative-pathogenic mycobacteria have few if any mechanisms to inhibit host cell immune responses but have evolved to mask some of their PAMP so they do not induce a strong innate response and finally 3) highly adapted virulent mycobacteria mask their PAMP and have mechanisms to inhibit host immune responses.
M. smegmatis strain (mc2 155) was obtained from Dr. William Jacobs Jr., and M. fortuitum strain (ATCC 6841) and M. kansasii strain Hauduroy (ATCC 12478) were obtained from the American Type Culture Collection http://www.atcc.org. M. bovis BCG Pasteur strain was obtained from the Trudeau Culture Collection (Saranac Lake, New York, United States). GFF-expressing BCG and M. smegmatis were generated by subcloning the enhanced GFP gene (Clonetech, http://www.clonetech.com) into the mycobacterial episomal expression vector pMV261. The resulting plasmid (pYU921) was transfected into competent cells by electroporation as previously described (Snapper et.al,). M. smegmatis was cultured in LB broth with 0.5% glycerol, 0.5% dextrose, and 0.05% TWEEN-80. M. fortuitum, M. kansasii, and M. bovis BCG were cultured in 7H9 broth with 0.5% glycerol, 0.5% dextrose, and 0.05% TWEEN-80, and 10% ADC enrichment. For selective media, 40 μg/ml kanamycin was added.
Bone marrow-derived macrophages and dendritic cells
Four to six weeks old BALB/c or C57BL/6 mice were obtained from the National Cancer Institute. Mice were used before twelve weeks of age and sacrificed by CO2 asphyxiation followed by cervical dislocation in accordance with IACUC approved protocols. The anterior limbs were flushed with DMEM supplemented with 2% fetal calf serum. Flushed bone marrow cells were then pelleted and treated with 1× red blood cells lysis buffer (eBiosciences) for 10 minutes then washed with 1× phosphate buffered saline. For macrophage differentiation, Cells were then plated on Petri dishes in DMEM medium supplemented with 10% heat inactivated fetal calf serum, 15% L929 cell supernatant, 1% Penicillin/Streptomycin, and 2% HEPES then incubated at 37°C/5% CO2. Cells were supplemented with additional medium on day three. On day 7, all non-adherent cells were washed off and the remaining adherent bone marrow-derived macrophages were seeded on appropriate plates for infection.
To derive dendritic cells, cells were incubated in medium as described for macrophages but containing 20 ng/ml murine GM-CSF (Peprotech) instead of L929 supernatant. 1 × 106 cells/well were added to 6 well plates containing 2.5 ml medium and an additional 2.5 ml medium/well was added on days 3, 6, and 9. All non-adherent dendritic cells were collected and seeded on appropriate plates for infection.
Cell cultures conditions and infection
For the apoptosis assays, 5 × 105 bone marrow-derived macrophages or dendritic cells in DMEM supplemented with 10% fetal calf serum, and 2% HEPES (infection media) were seeded on each well of a 24 well plates. Bacteria were grown to an OD600 ranging from 0.2 - 0.8, passed through a 26 Gauge needle 3 times and allowed to settle for 10 minutes. The infection was carried out at a multiplicity of infection (MOI) of 1:1, 3:1, and 10:1 for 2 h in duplicate wells, after which extracellular bacterial were removed by 3 washes using PBS. The cells were then incubated in DMEM infection medium supplemented with 100 μg/ml gentamycin (Invitrogen) for 20 h and the apoptosis assay was performed.
TNF and IL-12 assays
For the TNF secretion assays, 2 × 105 bone marrow-derived macrophages in DMEM infection media were seeded onto each well of 12 well plates and infected with bacteria as indicated above. The culture supernatants were then collected 20 h after incubation in infection media supplemented with 100 μg/ml gentamycin. The amount of TNF in supernatants was then measured via ELISA (BD Bioscience). The RAW IL-12 promoter cell line was created and used to measure IL-12 p40 induction as described in great detail in our previous publication .
TLR interaction assay
The Chinese hamster ovary (CHO) cells transfected with the inducible membrane protein CD25 under control of a region from the human E-selectin promoter containing nuclear fact-kB binding sites and expressing CD14 and either human Toll-like receptor 2 (TLR-2) or human TLF-4 were created as described in  kindly provided by Dr. D.T. Golenbock. Cells were used exactly as described previously by our group .
In most of the experiments the flow cytometry-based, hypodiploid assay was used for the detection of apoptosis after infection of bone marrow-derived macrophages and dendritic cells. Cells were collected after infection, pelleted and resuspended in propidium iodine (PI)/RNase buffer (BD Pharmingen) for 20 min and the percentage of hypodiploid positive cells was determined by flow cytometry in duplicates in the FL-2 channel at 580 nm (FACS-Calibur, BD Biosciences). The TUNEL assay was performed as suggested by the manufacturer (Roche) and described previously . The apoptosis induction mediated by lipoglycanes was analyzed via AnnexinV-Alex488 (Molecular Probes) and PI double staining and flow cytometry as described previously .
Caspase inhibition and TNF neutralization assays
BMDMs from BALB/c mice were treated with a pan-caspase-3/6/7 inhibitor (100 μM), caspase-3 inhibitor negative control (100 μM) (both from Calbiochem), anti murine TNF neutralizing antibody (5 μg/ml), isotype control antibody (5 μg/ml) (both from BD Bioscience), or pentoxifylline (Sigma, 100 μg/ml) for 1 h at 37°C/5% CO2 then infected with M. smegmatis at MOI 10:1 for 2 h as described above. Cells were then washed 3 times in PBS and incubated for an additional 20 h in DMEM infection media supplemented with the appropriate inhibitors and controls mentioned above and the apoptosis assay was performed.
ROS detection assay
Reactive oxygen species in BMDM and BMDD cells were detected at 2 h post infection using the ROS sensitive dye dihydroethidium (DHE) (Invitrogen). BMDM or BMDD cells were deprived of L929 supernatant or rGM-CSF respectively 16 hrs prior to infection and maintained in cytokine free media without phenol red for the length of the experiment. Post infection, cells were washed once in HBSS and then incubated in 2 μM DHE for 15 minutes. Cells were washed 3 times with HBSS, fixed with 4% paraformaldehyde and analyzed by flow cytometry.
We are grateful to Drs. J. Niguo and G. Puzo for gifts of LAM derived from BCG, M. fortuitum and M. smegmatis. Thanks to Dr. L. Kremer for providing LAM of M. kansasii. This study was supported by NIH/NIAID RO1 AI 072584-01-A2 to VB, the Heiser Program for Research in Leprosy and Tuberculosis postdoctoral fellowship of the New York Community Trust to HA and a grant by Scholar Rescue Fund to HA.
- Brown-Elliott BA, Wallace RJ: Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002, 15 (4): 716-746. 10.1128/CMR.15.4.716-746.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Briken V, Miller JL: Living on the edge: inhibition of host cell apoptosis by Mycobacterium tuberculosis. Future Microbiol. 2008, 3: 415-422. 10.2217/174609126.96.36.1995.PubMed CentralView ArticlePubMedGoogle Scholar
- Molloy A, Laochumroonvorapong P, Kaplan G: Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J Exp Med. 1994, 180 (4): 1499-1509. 10.1084/jem.180.4.1499.View ArticlePubMedGoogle Scholar
- Keane J, Shurtleff B, Kornfeld H: TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFNgamma independent manner. Tuberculosis (Edinb). 2002, 82 (2-3): 55-61. 10.1054/tube.2002.0322.View ArticleGoogle Scholar
- Fratazzi C, Arbeit RD, Carini C, Remold HG: Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J Immunol. 1997, 158 (9): 4320-4327.PubMedGoogle Scholar
- Pan H, Yan BS, Rojas M, Shebzukhov YV, Zhou H, Kobzik L, Higgins DE, Daly MJ, Bloom BR, Kramnik I: Ipr1 gene mediates innate immunity to tuberculosis. Nature. 2005, 434 (7034): 767-772. 10.1038/nature03419.PubMed CentralView ArticlePubMedGoogle Scholar
- Miller JL, Velmurugan K, Cowan M, Briken V: The Type I NADH Dehydrogenase of Mycobacterium Tuberculosis Counters Phagosomal NOX2 Activity to Inhibit TNF-α-mediated Host Cell Apoptosis. PLoS Pathog. 2010, 6 (4): e1000864-10.1371/journal.ppat.1000864.PubMed CentralView ArticlePubMedGoogle Scholar
- Velmurugan K, Chen B, Miller JL, Azogue S, Gurses S, Hsu T, Glickman M, Jacobs WR, Porcelli SA, Briken V: Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLOS Pathogens. 2007, 3 (7): e110-10.1371/journal.ppat.0030110.PubMed CentralView ArticlePubMedGoogle Scholar
- Hinchey J, Lee S, Jeon BY, Basaraba RJ, Venkataswamy MM, Chen B, Chan J, Braunstein M, Orme IM, Derrick SC: Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J Clin Invest. 2007, 117 (8): 2279-2288. 10.1172/JCI31947.PubMed CentralView ArticlePubMedGoogle Scholar
- Keane J, Remold HG, Kornfeld H: Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol. 2000, 164 (4): 2016-2020.View ArticlePubMedGoogle Scholar
- Giacomini E, Iona E, Ferroni L, Miettinen M, Fattorini L, Orefici G, Julkunen I, Coccia EM: Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol. 2001, 166 (12): 7033-7041.View ArticlePubMedGoogle Scholar
- Dao DN, Kremer L, Guerardel Y, Molano A, Jacobs WR, Porcelli SA, Briken V: Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages. Infect Immun. 2004, 72 (4): 2067-2074. 10.1128/IAI.72.4.2067-2074.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Schorey JS, Cooper AM: Macrophage signalling upon mycobacterial infection: the MAP kinases lead the way. Cell Microbiol. 2003, 5 (3): 133-142. 10.1046/j.1462-5822.2003.00263.x.View ArticlePubMedGoogle Scholar
- Roach SK, Schorey JS: Differential regulation of the mitogen-activated protein kinases by pathogenic and nonpathogenic mycobacteria. Infect Immun. 2002, 70 (6): 3040-3052. 10.1128/IAI.70.6.3040-3052.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Yadav M, Roach SK, Schorey JS: Increased mitogen-activated protein kinase activity and TNF-alpha production associated with Mycobacterium smegmatis-but not Mycobacterium avium-infected macrophages requires prolonged stimulation of the calmodulin/calmodulin kinase and cyclic AMP/protein kinase A pathways. J Immunol. 2004, 172 (9): 5588-5597.View ArticlePubMedGoogle Scholar
- Yadav M, Clark L, Schorey JS: Macrophage's proinflammatory response to a mycobacterial infection is dependent on sphingosine kinase-mediated activation of phosphatidylinositol phospholipase C, protein kinase C, ERK1/2, and phosphatidylinositol 3-kinase. J Immunol. 2006, 176 (9): 5494-5503.View ArticlePubMedGoogle Scholar
- Roach SK, Lee SB, Schorey JS: Differential activation of the transcription factor cyclic AMP response element binding protein (CREB) in macrophages following infection with pathogenic and nonpathogenic mycobacteria and role for CREB in tumor necrosis factor alpha production. Infect Immun. 2005, 73 (1): 514-522. 10.1128/IAI.73.1.514-522.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Riendeau CJ, Kornfeld H: THP-1 cell apoptosis in response to Mycobacterial infection. Infect Immun. 2003, 71 (1): 254-259. 10.1128/IAI.71.1.254-259.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Kopp E, Medzhitov R: Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol. 2003, 15 (4): 396-401. 10.1016/S0952-7915(03)00080-3.View ArticlePubMedGoogle Scholar
- Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A: Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science. 1999, 285 (5428): 736-739. 10.1126/science.285.5428.736.View ArticlePubMedGoogle Scholar
- Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST: Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 1999, 285 (5428): 732-736. 10.1126/science.285.5428.732.View ArticlePubMedGoogle Scholar
- Brennan PJ: Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb). 2003, 83 (13): 91-97. 10.1016/S1472-9792(02)00089-6.View ArticleGoogle Scholar
- Karakousis PC, Bishai WR, Dorman SE: Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cell Microbiol. 2004, 6 (2): 105-116. 10.1046/j.1462-5822.2003.00351.x.View ArticlePubMedGoogle Scholar
- Briken V, Porcelli SA, Besra GS, Kremer L: Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol. 2004, 53 (2): 391-403. 10.1111/j.1365-2958.2004.04183.x.View ArticlePubMedGoogle Scholar
- Torrelles JB, Schlesinger LS: Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinb). 2010Google Scholar
- Khoo KH, Dell A, Morris HR, Brennan PJ, Chatterjee D: Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium. J Biol Chem. 1995, 270 (21): 12380-12389. 10.1074/jbc.270.21.12380.View ArticlePubMedGoogle Scholar
- Maeda N, Nigou J, Herrmann JL, Jackson M, Amara A, Lagrange PH, Puzo G, Gicquel B, Neyrolles O: The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J Biol Chem. 2003, 278 (8): 5513-5516. 10.1074/jbc.C200586200.View ArticlePubMedGoogle Scholar
- Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevik T, Ingalls RR, Radolf JD: Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem. 1999, 274 (47): 33419-33425. 10.1074/jbc.274.47.33419.View ArticlePubMedGoogle Scholar
- Pitarque S, Larrouy-Maumus G, Payre B, Jackson M, Puzo G, Nigou J: The immunomodulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the mycobacterial cell surface. Tuberculosis (Edinb). 2008, 88 (6): 560-565. 10.1016/j.tube.2008.04.002.View ArticleGoogle Scholar
- Hoffmann C, Leis A, Niederweis M, Plitzko JM, Engelhardt H: Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc Natl Acad Sci USA. 2008, 105 (10): 3963-3967. 10.1073/pnas.0709530105.PubMed CentralView ArticlePubMedGoogle Scholar
- Sani M, Houben EN, Geurtsen J, Pierson J, de Punder K, van Zon M, Wever B, Piersma SR, Jimenez CR, Daffe M: Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLoS Pathog. 2010, 6 (3): e1000794-10.1371/journal.ppat.1000794.PubMed CentralView ArticlePubMedGoogle Scholar
- Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knabb JR, Dean K, Franzoso G: The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ. 2006, 13 (5): 712-729. 10.1038/sj.cdd.4401865.View ArticlePubMedGoogle Scholar
- Kurokawa M, Kornbluth S: Caspases and kinases in a death grip. Cell. 2009, 138 (5): 838-854. 10.1016/j.cell.2009.08.021.PubMed CentralView ArticlePubMedGoogle Scholar
- Beltan E, Horgen L, Rastogi N: Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria. Microb Pathog. 2000, 28 (5): 313-318. 10.1006/mpat.1999.0345.View ArticlePubMedGoogle Scholar
- Faldt J, Dahlgren C, Ridell M: Difference in neutrophil cytokine production induced by pathogenic and non-pathogenic mycobacteria. APMIS. 2002, 110 (9): 593-600. 10.1034/j.1600-0463.2002.1100901.x.View ArticlePubMedGoogle Scholar
- Lee SB, Schorey JS: Activation and mitogen-activated protein kinase regulation of transcription factors Ets and NF-kappaB in Mycobacterium-infected macrophages and role of these factors in tumor necrosis factor alpha and nitric oxide synthase 2 promoter function. Infect Immun. 2005, 73 (10): 6499-6507. 10.1128/IAI.73.10.6499-6507.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M: Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell. 2005, 120 (5): 649-661. 10.1016/j.cell.2004.12.041.View ArticlePubMedGoogle Scholar
- Wolf AJ, Linas B, Trevejo-Nunez GJ, Kincaid E, Tamura T, Takatsu K, Ernst JD: Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol. 2007, 179 (4): 2509-2519.View ArticlePubMedGoogle Scholar
- Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, Moura IC, Lennon-Dumenil AM, Seabra MC, Raposo G, Amigorena S: NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell. 2006, 126 (1): 205-218. 10.1016/j.cell.2006.05.035.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.